Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study

Autor: Wieke W Kremer, Johannes Berkhof, Maaike CG Bleeker, Daniëlle AM Heideman, Nienke E van Trommel, Marchien W van Baal, Harold R Verhoeve, Chris JLM Meijer, Gemma G Kenter

Publikováno v: BMJ Open, Vol 9, Iss 7 (2019)

Introduction The clinical course of high-grade cervical intraepithelial neoplasia (CIN2/3) is characterised by a high spontaneous regression rate. Histological assessment is unable to differentiate between CIN2/3 lesions likely to regress and those l

Externí odkaz: https://doaj.org/article/d614a9aafa4c4986ab14deced4800b7a

2022-RA-580-ESGO Endometrial cancer detection by DNA methylation testing in cervical scrapes, cervicovaginal self-samples and urine

Autor: Birgit MM Wever, Rianne van den Helder, Annina P van Splunter, Nienke E van Trommel, Renske DM Steenbergen, Maaike CG Bleeker

Publikováno v: Endometrial cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::020ed45396eeda217920bcc67dae1b7b
https://doi.org/10.1136/ijgc-2022-esgo.216

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme

Autor: Ugyen Tshomo, Silvia Franceschi, Dorji Dorji, Iacopo Baussano, Vanessa Tenet, Peter JF Snijders, Chris JLM Meijer, Maaike CG Bleeker, Tarik Gheit, Massimo Tommasino, Gary M Clifford

Publikováno v: BMC Infectious Diseases, 14:408. BioMed Central
Tshomo, U, Franceschi, S, Dorji, D, Baussano, L, Tenet, V, Snijders, P J F, Meijer, C J L M, Bleeker, M C G, Gheit, T, Tommasino, M & Clifford, G M 2014, ' Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme ', BMC Infectious Diseases, vol. 14, 408 . https://doi.org/10.1186/1471-2334-14-408
BMC Infectious Diseases

Background Cervical cancer is the most common female cancer in Bhutan, the first low/middle-income country to implement a national human papillomavirus (HPV) vaccination programme. Methods To provide a robust baseline for future evaluations of vaccin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af38b4c3b465b424a5e7857b7019c605
https://research.vumc.nl/en/publications/8bf545dd-8b1f-4abe-a729-b075325c3284